Cumberland Pharmaceuticals (CPIX) Operating Margin (2016 - 2025)
Historic Operating Margin for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to 23.7%.
- Cumberland Pharmaceuticals' Operating Margin fell 50500.0% to 23.7% in Q3 2025 from the same period last year, while for Sep 2025 it was 7.9%, marking a year-over-year increase of 213700.0%. This contributed to the annual value of 16.99% for FY2024, which is 71700.0% up from last year.
- As of Q3 2025, Cumberland Pharmaceuticals' Operating Margin stood at 23.7%, which was down 50500.0% from 6.9% recorded in Q2 2025.
- In the past 5 years, Cumberland Pharmaceuticals' Operating Margin ranged from a high of 11.03% in Q1 2025 and a low of 66.07% during Q4 2023
- Its 5-year average for Operating Margin is 17.73%, with a median of 17.65% in 2024.
- As far as peak fluctuations go, Cumberland Pharmaceuticals' Operating Margin plummeted by -411000bps in 2023, and later surged by 484100bps in 2024.
- Quarter analysis of 5 years shows Cumberland Pharmaceuticals' Operating Margin stood at 52.33% in 2021, then soared by 52bps to 24.97% in 2022, then plummeted by -165bps to 66.07% in 2023, then soared by 73bps to 17.65% in 2024, then crashed by -34bps to 23.7% in 2025.
- Its Operating Margin was 23.7% in Q3 2025, compared to 6.9% in Q2 2025 and 11.03% in Q1 2025.